Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 15/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 13/20 | 0.55 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.47 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9117072 | 0.86 | PTGS2 (0.66) | PTGS2PTGS1 | |
| SCHEMBL8974619 | 0.86 | PTGS2 (0.57) | PTGS2PTGS1MAOAMAOBSOS1 | |
| SCHEMBL8974702 | 0.86 | PTGS2 (0.43) | PTGS2PTGS1MAOAMAOBCHRNA7 | |
| SCHEMBL8974725 | 0.86 | PTGS2 (0.46) | PTGS2PTGS1MAOAMAOBCHRNA7 | |
| SCHEMBL8973810 | 0.85 | PTGS2 (0.55) | PTGS2PTGS1MAOAMAOBCHRNA7 | |
| SCHEMBL8973851 | 0.85 | PTGS2 (0.59) | PTGS2PTGS1MAOAMAOBCHRNA7 | |
| SCHEMBL8974424 | 0.84 | KIF11 (0.62) | PTGS2PTGS1CHRNA7CA12CA2 | |
| SCHEMBL8974376 | 0.84 | PTGS2 (0.45) | PTGS2PTGS1CA12CA2CA9 | |
| SCHEMBL8974294 | 0.84 | CA2 (0.50) | CA12CA2CA9 | |
| SCHEMBL214628 | 0.83 | PTGS2 (0.56) | PTGS2PTGS1MAOAMAOBSOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5576339-A | Pyridyl substituted cyclopentadienes for the treatment of inflamation | HUANG HORNG-CHIH (US) | 1996-11-19 | — | — | US | disclosed |
| WO-1995030656-A1 | SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1995-11-16 | — | — | WO | disclosed |
| US-5418254-A | Side effect reduction | G. D. SEARLE & CO. (US) | 1995-05-23 | — | — | US | disclosed |